Ifetroban Sodium

Drug identity checked against registry records

Also recorded as ifetroban

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)NCT05571059Cumberland PharmaceuticalsPhase 2Recruiting2028-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.